Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strontium ranelate effectiveness on bone protection after bisphosphonate therapy in postmenopausal osteoporosis
2005-003138-16Phase 4Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of strontium ranelate in osteoporosis (2 arms), sponsored by Hull University Teaching Hospitals. Primary endpoint: Change in bone mineral density at 1 year. Started Jul 2005; status: completed.
02
Drugs
strontium ranelate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2005-003138-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003138-16.